← All indications
Psychotic Disorders
Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
Subtype terms (1)
More specific conditions that are subtypes of Psychotic Disorders in the MeSH hierarchy.
- Psychoses, Substance-Induced
2 drugs approved
Drugs by status
Approved for this indication (16)
Phase 4 trials (72)
- flupentixol
- simvastatin
- metformin
- melatonin
- allopurinol
- acamprosate
- agomelatine
- lorcaserin
- acetylcysteine
- bromperidol
- lamotrigine
- citalopram
- clonazepam
- raloxifene
- exenatide
- cycloserine
- prednisone
- progesterone
- valproic acid
- duloxetine
- galantamine
- fluspirilene
- escitalopram
- naltrexone
- guanfacine
- insulin human
- icosapent ethyl
- iloperidone
- amantadine
- etomidate
- +42 more
Phase 3 trials (22)
Phase 2 trials (42)
- sarcosine
- bi 409306
- vitamin d3
- methylprednisolone
- bifeprunoxum
- donu
- dydrogesterone
- gabapentin
- ginseng
- levetiracetam
- tryptophan
- nitroprusside
- oleoylestrone
- pentosan polysulfate sodium
- pipamperone
- immune globulin (human)
- Brilaroxazine
- sapropterin
- ceftriaxone
- siltuximab
- sodium benzoate
- rimonabant
- ondansetron
- curcumin
- daaoi-1
- betahistine mesilate
- rituximab
- multivitamins
- benzyl benzoate
- org-34517
- +12 more
Phase 1 trials (12)
Other trials (39)
- maltodextrin
- nitroglycerin
- lurasidone
- pbr111
- brexpiprazole
- artemisinin
- alprazolam
- benzatropine
- l-carnosine
- folic acid
- ziprasidone
- sertraline
- mesalamine
- cyanocobalamin
- loxapine
- theanine
- olanzapine
- dipyridamole
- risperidone
- tetrabenazine
- tetrahydrocannabinol
- ashwagandha extract
- autologous microbiome
- bifidobacterium longum
- luteolin
- aripiprazole
- isradipine
- quetiapine
- pyridoxine
- blood plasma
- +9 more
Organizations
Organization Involved with Phase 4 Indications (153)
- Abbott
- Acadia Pharmaceuticals
- Amylin
- Takeda
- Cephalon
- Bristol-Myers Squibb
- Servier
- Forest Laboratories
- AstraZeneca
- Eli Lilly
- Pfizer
- Sanofi-Synthelabo
- Alkermes
- GlaxoSmithKline
- Handok Pharmaceuticals Co., Ltd.
- Sunovion
- Azur Pharma, Inc
- Otsuka
- The Dana Foundation
- Veterans Medical Research Foundation
- Research Foundation for Mental Hygiene, Inc.
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute of Mental Health (NIMH)
- National Institute on Aging (NIA)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institute on Drug Abuse (NIDA)
- Huazhong University of Science and Technology
- Aarhus University
- Abarbanel Mental Health Center
- +123 more
Organization Involved with Phase 3 Indications (62)
- Merck
- Wyeth
- Bukwang Pharmaceutical
- Corcept Therapeutics
- Cognitive Research Corporation
- Solvay
- National Institute of Mental Health and Neuro Sciences, India
- UMC Utrecht
- Alexandria University
- Case Western Reserve University
- Clinic for Psychiatric Disorders
- Diakonhjemmet Hospital
- Herzog Hospital
- Norwegian University of Science and Technology
- North District Hospital
- Saint-Joseph University
- University of Oslo
- University of Southern California
- Yale University
- Zhejiang University
- Clinic for Psychiatric Disorders, Dr Laza Lazarevic
- Taipei Veteran General hospital
- University of Amsterdam
- Orygen Youth Research Centre
- Rush University
- The University of Hong Kong
- ZNA Antwerpen
- YuLi Hospital
- Huddinge Hospital, Stockholm
- Castle Peak Hospital
- +32 more
Organization Involved with Phase 2 Indications (65)
- Bausch Health Companies
- Genentech
- BioLineRx, Ltd.
- Braeburn Pharmaceuticals
- Mediti Pharma Inc.
- Neurocrine Biosciences
- Orexigen Therapeutics, Inc
- Reviva Pharmaceuticals
- Boehringer Ingelheim
- PharmaNeuroBoost N.V.
- Fundación Pública Andaluza
- American Heart Association
- Dow University of Health Sciences
- Katholieke Universiteit Leuven
- Mental Health Services in the Capital Region, Denmark
- Newcastle University
- Queen's University, Belfast
- Russian Academy of Medical Sciences
- Sheppard Pratt Health System
- University of Groningen
- University of Puerto Rico
- Wayne State University
- Laval University
- University of California, Irvine
- University of Cambridge
- University of Colorado, Denver
- Uppsala University
- Bahauddin Zakariya University
- GW Research
- Worldwide Clinical Trials
- +35 more
Organization Involved with Phase 1 Indications (13)
Organization Involved with Other Experimental Indications (23)
- University of Pennsylvania
- Brown University
- Hacettepe University
- Liverpool John Moores University
- St. Luke's-Roosevelt Hospital Center
- Tufts University
- University of Minnesota
- Trinity College Dublin
- Medical University of Vienna
- Louisiana State University
- Royal Liverpool & Broadgreen University Hospitals NHS Truts
- Hennepin Healthcare
- Kwai Chung Hospital
- Zucker Hillside Hospital
- LIJMC
- University of Texas, San Antonio
- South London and Maudsley NHS Foundation Trust
- McPin Foundation
- Robert Wood Johnson Foundation
- Government of Hong Kong
- Canadian Psychiatric Research Foundation
- San Francisco Brain Research Institute
- Government of Ontario